Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : DPII: Discovery Partners Int'l -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (44)	12/5/2005 10:35:56 AM
From: Mike McFarland	Respond to of 111

History repeats--shares traded down around $2 1/4 in the winter of 2002/3 and again now in 2005/6. My position is down 25%, which is just terrible for somebody claims to swingtrade microcap biotechs. I should have been stopped out, but I am going to continue to hold the position. My trading account has not got anywhere the past five years--but I haven't drained the account either. Maybe it is enough to break even. DPI hasn't done anything at all unreasonable--I don't think their effort to burn less cash is a reason to part with my shares. The business is decidedly dull, I would like to see them merge with another microcap biotech--one that needs cash but has prospects. If they don't get bought out or merge, this is indeed going to be a value trap. But I saw the chart for Rigel just now, getting whacked for, what, a 60% loss overnight. I can't be too unhappy--I'll finish the year down about 15% overall in my trading account.